₹ 2.0 Cr
Volume Transacted
(Jan 14, 2025)
34.8 K
Stocks Traded
(Jan 14, 2025)
Last Updated on: Jan 14, 2025
Granules India Ltd
NSE: GRANULES
EPS
₹ 20.09
Last updated on: Jan 14, 2025
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Granules India Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 14,172 Cr
EPS
₹ 20.1
P/E Ratio (TTM) *
29.1
P/B Ratio (TTM) *
4.1
Day’s High *
592.0
Day’s Low
₹ 556.65
DTE *
0.3
ROE *
14.2
52 Week High
₹ 724.55
52 Week Low
₹ 382.05
ROCE *
16.9
* All values are consolidated
Last Updated time: 14 Jan 9.00 AM
* All values are consolidated
Last Updated time: 14 Jan 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 584.45 | 556.65 | 592 | 556.65 |
13 Jan 2025 | 567.5 | 582.35 | 595.45 | 564.6 |
10 Jan 2025 | 593.9 | 607.75 | 607.75 | 586.2 |
09 Jan 2025 | 605.9 | 605 | 616.5 | 604.45 |
08 Jan 2025 | 608.8 | 617 | 619.1 | 600.95 |
07 Jan 2025 | 616.75 | 611.8 | 621.1 | 610.05 |
06 Jan 2025 | 607.75 | 607.9 | 619 | 605.8 |
03 Jan 2025 | 606.1 | 614.3 | 614.3 | 599.75 |
02 Jan 2025 | 607.95 | 597.05 | 609.85 | 595.2 |
01 Jan 2025 | 597.85 | 594.95 | 599.95 | 587.6 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 584.45 |
13 Jan 2025 | 567.5 |
10 Jan 2025 | 593.9 |
09 Jan 2025 | 605.9 |
08 Jan 2025 | 608.8 |
07 Jan 2025 | 616.75 |
06 Jan 2025 | 607.75 |
03 Jan 2025 | 606.1 |
02 Jan 2025 | 607.95 |
01 Jan 2025 | 597.85 |
Strength
4
S
Weakness
1
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 14,173
Asset Value
₹ 3,064
3.6 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Granules India Ltd | 20 | 14,172 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,24,382 |
Divis Laboratories Ltd | 69 | 1,59,224 |
Cipla Ltd | 57 | 1,16,943 |
Dr Reddys Laboratories Ltd | 63 | 1,11,588 |
Mankind Pharma Ltd | 51 | 1,10,215 |
Historical Market Cap of Granules India Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Granules India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Granules India Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Granules India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Granules India appoints Global Head of Quality
Granules India announced the appointment of Dr. Rajesh Kapoor has been appointed as Global...
09 Jan 2025 12:51
Granules India to conduct board meeting
Granules India will hold a meeting of the Board of Directors of the Company on 24 January ...
08 Jan 2025 16:37
Granules arm gets USFDA nod for ADHD drug
The approved drug is available in multiple strengths: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, a...
17 Dec 2024 11:36
Granules India receives USFDA approval for Lisdexamfetamine Dimesylate Chewable Tablets
Granules India announced today that its wholly-owned foreign subsidiary, Granules Pharmace...
17 Dec 2024 14:07
Granules India Ltd gains for fifth session
Granules India Ltd is up for a fifth straight session in a row. The stock is quoting at Rs...
10 Dec 2024 13:00
Granules India Ltd leads losers in 'A' group
C.E. Info Systems Ltd, Zen Technologies Ltd, Deepak Nitrite Ltd and Avalon Technologies Lt...
03 Dec 2024 15:00
Unlimited trading starting at just Rs. 249*